Drugs at age 17 - Trends, use context and risk-ranking

 

Drugs at age 17

Tendances n° 49, OFDT, 4 p.
September 2006

The 2005 ESCAPAD survey (Survey on Health and Consumption on Call-up and Preparation for Defence Day) is the fifth nationwide survey of its kind to be organised. The survey completes the device introduced by OFTD in order to monitor usage throughout the adult population (the Baromètre Santé or "Health Barometer" organised under the scientific supervision of the Inpes), and the ESPAD project organised among the school-age population (the European School Survey Project on Alcohol and other Drugs, in collaboration with the Inserm). It covers mainland France but also the overseas départements and local authorities, using the same methodology for each. The data from the 2005 survey was drawn from the replies of 29,393 young people in mainland France aged 17 years old at the time the survey was carried out. It makes it possible to describe trends over five years but also includes new questions concerning the context of alcohol and cannabis use, the driving of a motor vehicle under the influence and accidents related to the consumption of these products. Finally, thanks to the introduction of a new question, cannabis sourcing methods can now also be identified and recorded.

Authors :
François Beck, Stéphane Legleye, Stanislas Spilka

Download the PDF file (129 Ko)

Drugs in Europe


2017 EMCDDA European Drug Report

What do the latest data tell us about the European drug market? What are the new trends in drug use among European adults and school students? What are the harms associated with drug use and what is being done to counter them? These and other questions are explored in the 2017 EMCDDA European Drug Report.

Country drug reports

Developed by the EMCDDA, in cooperation with the Reitox national focal points, these graphic-rich reports cover: drug use and public health problems; drug policy and responses and drug supply.

The European Union and the drug phenomenon

The European Union & the drug phenomenon : Frequently asked questions , joint publication between the EMCDDA and the European Commission, october 2010, 12 p.